Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 3,929,039 | 3,904,456 | -24,583 | $139.17M | $145.40M | 14.15% | +$6.24M |
| Krystal Biotech, Inc.(KRYS) | 663,471 | 661,388 | -2,083 | $91.20M | $116.75M | 11.36% | +$25.55M |
| Stoke Therapeutics, Inc.(STOK) | 4,375,931 | 4,175,542 | -200,389 | $49.67M | $98.13M | 9.55% | +$48.46M |
| Zymeworks Inc.(ZYME) | 4,150,627 | 3,705,750 | -444,877 | $52.09M | $63.29M | 6.16% | +$11.20M |
| ADC Therapeutics SASHS(ADCT) | 15,666,731 | 15,666,731 | 0 | $41.99M | $62.67M | 6.10% | +$20.68M |
| Immunome, Inc.(IMNM) | 4,872,225 | 5,023,385 | +151,160 | $45.31M | $58.82M | 5.72% | +$13.51M |
| LivaNova PLCSHS(LIVN) | 934,271 | 926,799 | -7,472 | $42.06M | $48.55M | 4.72% | +$6.48M |
| REGENXBIO Inc.(RGNX) | 4,775,717 | 4,693,389 | -82,328 | $39.21M | $45.29M | 4.41% | +$6.08M |
| Akero Therapeutics Inc | 774,311 | 747,818 | -26,493 | $41.32M | $35.51M | 3.45% | -$5.81M |
| Nurix Therapeutics, Inc.(NRIX) | 3,732,888 | 3,678,394 | -54,494 | $42.52M | $33.99M | 3.31% | -$8.53M |
| Beam Therapeutics Inc.(BEAM) | 1,423,411 | 1,387,559 | -35,852 | $24.21M | $33.68M | 3.28% | +$9.46M |
| Cogent Biosciences, Inc.(COGT) | 1,448,040 | 2,209,118 | +761,078 | $10.40M | $31.72M | 3.09% | +$21.33M |
| Absci Corporation | 8,253,316 | 8,253,316 | 0 | $21.21M | $25.09M | 2.44% | +$3.88M |
| Neurogene Inc.(NGNE) | 1,276,676 | 1,299,022 | +22,346 | $19.09M | $22.51M | 2.19% | +$3.43M |
| 89bio Inc | 1,545,208 | 1,473,136 | -72,072 | $15.17M | $21.66M | 2.11% | +$6.48M |
| IDEAYA Biosciences, Inc.(IDYA) | 432,494 | 742,017 | +309,523 | $9.09M | $20.19M | 1.96% | +$11.10M |
| Annexon, Inc.(ANNX) | 6,300,644 | 6,300,644 | 0 | $15.12M | $19.22M | 1.87% | +$4.10M |
| Fate Therapeutics, Inc.(FATE) | 12,872,946 | 12,872,946 | 0 | $14.42M | $16.22M | 1.58% | +$1.80M |
| Rapt Therapeutics Inc | 630,686 | 552,594 | -78,092 | $5.05M | $14.25M | 1.39% | +$9.21M |
| Shattuck Labs, Inc.(STTK) | 5,539,724 | 5,539,724 | 0 | $4.39M | $13.24M | 1.29% | +$8.85M |
| Solid Biosciences Inc | 1,915,926 | 1,899,342 | -16,584 | $9.33M | $11.72M | 1.14% | +$2.39M |
| Silence Therapeutics plcADS(SLN) | 2,164,777 | 2,164,777 | 0 | $12.56M | $11.24M | 1.09% | -$1.32M |
| Nuvation Bio Inc.CL A(NUVB) | 3,031,009 | 3,031,009 | 0 | $5.91M | $11.21M | 1.09% | +$5.30M |
| Keros Therapeutics, Inc.(KROS) | 552,506 | 552,506 | 0 | $7.38M | $8.74M | 0.85% | +$1.36M |
| Celldex Therapeutics, Inc.(CLDX) | 343,026 | 327,008 | -16,018 | $6.98M | $8.46M | 0.82% | +$1.48M |
| Atara Biotherapeutics Inc | 441,701 | 441,701 | 0 | $3.41M | $6.33M | 0.62% | +$2.92M |
| Amicus Therapeutics Inc COM | 1,188,998 | 777,178 | -411,820 | $6.81M | $6.12M | 0.60% | -$688.8K |
| ALX Oncology Holdings Inc.(ALXO) | 3,391,455 | 3,332,983 | -58,472 | $1.41M | $6.10M | 0.59% | +$4.69M |
| Establishment Labs Holdings Inc.(ESTA) | 136,495 | 129,364 | -7,131 | $5.83M | $5.30M | 0.52% | -$527.1K |
| CeriBell, Inc.(CBLL) | 435,239 | 435,239 | 0 | $8.15M | $5.00M | 0.49% | -$3.15M |
| Xeris Biopharma Holdings Inc | 451,099 | 451,099 | 0 | $2.11M | $3.67M | 0.36% | +$1.57M |
| Ventyx Biosciences Inc | 1,114,529 | 1,073,386 | -41,143 | $2.39M | $3.34M | 0.32% | +$953.1K |
| Lava Therapeutics NvSHS | 2,074,372 | 2,074,372 | 0 | $2.74M | $3.24M | 0.31% | +$497.8K |
| Repare Therapeutics Inc | 1,586,174 | 1,586,174 | 0 | $2.20M | $2.79M | 0.27% | +$586.9K |
| Invivyd, Inc.(IVVD) | 2,285,320 | 2,285,320 | 0 | $1.63M | $2.51M | 0.24% | +$879.8K |
| Pliant Therapeutics, Inc.(PLRX) | 1,632,577 | 1,591,695 | -40,882 | $1.89M | $2.36M | 0.23% | +$461.9K |
| Replimune Group, Inc.(REPL) | 4,664,791 | 535,818 | -4,128,973 | $43.34M | $2.25M | 0.22% | -$41.09M |
| Prime Medicine, Inc.(PRME) | 2,074,350 | 87,118 | -1,987,232 | $5.12M | $482.6K | 0.05% | -$4.64M |
| Kalaris Therapeutics, Inc.(KLRS) | 82,955 | 82,955 | 0 | $221.5K | $479.5K | 0.05% | +$258.0K |
| Boundless Bio, Inc.(BOLD) | 589,034 | 245,458 | -343,576 | $594.9K | $301.9K | 0.03% | -$293.0K |
| 4d Molecular Therapeutics In | 112,168 | 0 | -112,168 | $416.1K | $0 | — | -$416.1K |
| Biohaven Ltd.(BHVN) | 729,515 | 0 | -729,515 | $10.29M | $0 | — | -$10.29M |
| Boston Scientific Corporation(BSX) | 85,301 | 0 | -85,301 | $9.16M | $0 | — | -$9.16M |
| Hinge Health, Inc.CL A(HNGE) | 300,000 | 0 | -300,000 | $15.53M | $0 | — | -$15.53M |
| Igm Biosciences Inc | 2,952,131 | 0 | -2,952,131 | $3.31M | $0 | — | -$3.31M |
| Kymera Therapeutics, Inc.(KYMR) | 803,289 | 0 | -803,289 | $35.06M | $0 | — | -$35.06M |
| Penumbra, Inc.(PEN) | 18,818 | 0 | -18,818 | $4.83M | $0 | — | -$4.83M |
| Verve Therapeutics Inc | 740,261 | 0 | -740,261 | $8.31M | $0 | — | -$8.31M |